Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pertussis Immune Globulin in Severe Childhood Pertussis
NCT00004422Phase 3
Key facts
- Status
- Completed
- Start
- Aug 1997
- Sponsor
- IWK Health
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Conditions
- pertussis
01
Overview
Phase 3, randomised trial in pertussis comparing Pertussis Immune Globulin with Placebo (2 arms). Started Aug 1997; status: completed.
02
Design
2 arms- Study design
- Randomized
Pertussis Immune Globulin
Single infusion of high titer pertussis immune globulin
Placebo
Single infusion of 0.9% saline
03
Who it enrols
Children with documented infection with Bordetella pertussis.
Beyond the preview
Go deeper on NCT00004422.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004422.